GlassScriptPhysician profile
Sean Michael Kalmeyer
NPI 1790412120
$3,941.08
in general payments reported to CMS, 2019-2025
19 companies · $2,426 in 2025
The $2,426 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.54 · 2023: $397 · 2024: $1,101 · 2025: $2,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,320 · Travel and Lodging: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,320.33 |
| Travel and Lodging | $604.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,072.62 | 2025 | Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $562.83 | 2024-2025 | |
| Heartflow, INC. | $556.94 | 2023-2025 | Ffrct |
| Amgen INC. | $551.58 | 2024-2025 | Repatha, Repatha |
| Novo Nordisk INC | $248.56 | 2024-2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $213.03 | 2024-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $164.65 | 2023-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $150.47 | 2023-2024 | Watchman Access System, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $72.49 | 2023-2025 | Farxiga, Wainua |
| Janssen Pharmaceuticals, INC | $65.99 | 2023 | Xarelto |
| Terumo Medical Corporation | $62.05 | 2024 | Glidewire |
| Kiniksa Pharmaceuticals International, Plc | $49.46 | 2024 | Arcalyst |
| Abiomed | $46.12 | 2024-2025 | Impella |
| Teleflex LLC | $30.47 | 2025 | Chocolate |
| Irhythm Technologies, INC. | $23.76 | 2024 | Zio Xt Patch, Zio Monitor |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $18.57 | 2023 | |
| Mannkind Corporation | $18.19 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.76 | 2025 | Jardiance |
| Csl Behring | $16.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Kalmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.